Skip to content

HAART can be safely interrupted for over a year by patients with lowest ever CD4 cell count above 250 and a sustained treatment CD4 cell count of 500 or more

Report suggests short course of rifampicin/isoniazid as effective as standard course of isoniazid for the treatment of latent TB

Pilot study suggests that Kaletra maintenance therapy safe

European consensus meeting draws up guidelines on HIV and hepatitis treatment

Small number of UK HIV-positive patients at risk of exhausting treatment options

'Dear Dr' letter issued about risks of using tenofovir and ddI together

US pressure for UN needle/syringe exchange u-turn 'overrules science', campaigners say in open letter prior to Vienna drugs meeting

US approves Pegasys with ribavirin for chronic HCV in HIV/HCV coinfected adults; adds NRTI warning

Slow progress on HIV vaccines reported at CROI